<abstract xmlns="http://www.w3.org/1999/xhtml"><p>The assortment of neuroprotective medications, presented in the pharmaceutical market of Ukraine, has been investigated in
the article. Correlation of medications of home and foreign manufacture within the limits of each pharmacotherapeutic group
of medications was determined.
The analysis of the assortment of neuroprotective medications has been also conducted regarding dosage forms.
During research of assortment of neuroprotective action medications, present in the market of Ukraine, we used data of the
State Register of Medicinal Remedies of the Ministry of Health of Ukraine. While conducting marketing analysis of the market of
medications, we adhered to the АТС classification system.
It was determined that home manufacturers supply the internal pharmaceutical market with 38.8% of preparations of the investigated
group. Herewith, leading positions in terms of supply volume belong to ZAT (Close Joint-Stock Company), pharmaceutical
firm “Darnytsia” and JSC “Galychpharm”. Preparations of each of the above-mentioned firms make 10.7% of the general
assortment of home-produced medications.
Rating of 25 foreign countries–suppliers of medications of neuroprotective action to the pharmaceutical market of Ukraine
showed that the leader in terms of volume of the presented medications is Russia, whose medications make 16.4% of the assortment
of neuroprotective medications of foreign manufacture. The second place belongs to Germany (15%), and India (11.6%)
takes the third place.
There was disclosed expediency of expansion of home-produced preparations nomenclature and their dosage forms for ischemic
stroke treatment.</p></abstract>

The assortment of neuroprotective medications, presented in the pharmaceutical market of Ukraine, has been investigated in
the article. Correlation of medications of home and foreign manufacture within the limits of each pharmacotherapeutic group
of medications was determined.
The analysis of the assortment of neuroprotective medications has been also conducted regarding dosage forms.
During research of assortment of neuroprotective action medications, present in the market of Ukraine, we used data of the
State Register of Medicinal Remedies of the Ministry of Health of Ukraine. While conducting marketing analysis of the market of
medications, we adhered to the АТС classification system.
It was determined that home manufacturers supply the internal pharmaceutical market with 38.8% of preparations of the investigated
group. Herewith, leading positions in terms of supply volume belong to ZAT (Close Joint-Stock Company), pharmaceutical
firm “Darnytsia” and JSC “Galychpharm”. Preparations of each of the above-mentioned firms make 10.7% of the general
assortment of home-produced medications.
Rating of 25 foreign countries–suppliers of medications of neuroprotective action to the pharmaceutical market of Ukraine
showed that the leader in terms of volume of the presented medications is Russia, whose medications make 16.4% of the assortment
of neuroprotective medications of foreign manufacture. The second place belongs to Germany (15%), and India (11.6%)
takes the third place.
There was disclosed expediency of expansion of home-produced preparations nomenclature and their dosage forms for ischemic
stroke treatment.

Marketing Researches of Market of Medications
of Neuroprotective Action in Ukraine

National University of Pharmacy, Kharkiv, Ukraine,
Department of Social Pharmacy

European Pharmaceutical Journal

The assortment of neuroprotective medications, presented in the pharmaceutical market of Ukraine, has been investigated in
the article. Correlation of...

Marketing Researches of Market of Medications of Neuroprotective Action in Ukraine

Data publikacji: 27 cze 2013

Zakres stron: 15 - 20

DOI: https://doi.org/10.2478/afpuc-2013-0012

This content is open access.